Replimune Group Ownership | Who Owns Replimune Group?
Replimune Group Ownership Summary
Replimune Group is owned by 98.18% institutional investors, 4.61% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 14.06% of REPL shares. T. Rowe Price New Horizons is the top mutual fund, with 6.06% of its assets in Replimune Group shares.
REPL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Replimune Group | 98.18% | 4.61% | -2.79% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 11.05M | 14.06% | $133.76M |
| Price t rowe associates inc /md/ | 10.96M | 13.95% | $132.76M |
| Fcpm iii services b.v. | 4.87M | 7.31% | $43.80M |
| Blackrock funding, inc. /de | 5.57M | 7.08% | $67.41M |
| Blackrock | 4.71M | 7.08% | $42.42M |
| Redmile group | 4.91M | 6.24% | $59.41M |
| Vanguard group | 3.60M | 4.58% | $43.55M |
| Sofinnova investments | 3.15M | 4.01% | $38.14M |
| Omega fund management | 2.46M | 3.70% | $22.15M |
| Tang capital management | 2.70M | 3.44% | $32.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 2.46M | 16.41% | $22.15M |
| Fcpm iii services b.v. | 4.87M | 6.46% | $43.80M |
| Redmile group | 4.91M | 4.14% | $59.41M |
| Nan fung group | 321.75K | 3.33% | $3.90M |
| Sofinnova investments | 3.15M | 2.78% | $38.14M |
| Tang capital management | 2.70M | 2.16% | $32.70M |
| Velan capital investment management lp | 181.37K | 1.90% | $2.20M |
| Bioimpact capital | 950.00K | 1.63% | $11.50M |
| Rosalind advisors | 260.00K | 1.61% | $3.15M |
| Baker bros. advisors lp | 11.05M | 1.43% | $133.76M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sofinnova investments | 3.15M | 2.78% | 3.10M |
| Boxer capital | 1.54M | 0.73% | 1.54M |
| Tang capital management | 2.70M | 2.16% | 1.50M |
| Rtw investments, lp | 1.13M | 0.16% | 1.13M |
| Price t rowe associates inc /md/ | 10.96M | 0.02% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.16M | 0.00% | -5.33M |
| Atlas venture life science advisors | - | - | -2.10M |
| Braidwell lp | 1.48M | 0.53% | -1.59M |
| Camber capital management lp | - | - | -1.35M |
| Jefferies financial group | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boxer capital | 1.54M | 0.73% | 1.54M | $13.83M |
| Rtw investments, lp | 1.13M | 0.16% | 1.13M | $10.20M |
| Bioimpact capital | 950.00K | 1.63% | 950.00K | $11.50M |
| Marshall wace, llp | 896.18K | 0.01% | 896.18K | $10.85M |
| Artisan partners limited partnership | 611.01K | 0.01% | 611.01K | $7.40M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Global retirement partners | -32.00 |
| Riggs asset managment | -58.00 |
| Capital performance advisors llp | -76.00 |
| Truvestments capital | -80.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 170 | 6.25% | 81,976,905 | 5.26% | 98 | 1.13% | 88 | -11.11% | 49 | 48.48% |
| Dec 31, 2024 | 91 | -38.10% | 20,304,371 | -70.81% | 25 | 0.33% | 55 | -30.38% | 17 | -56.41% |
| Sep 30, 2024 | 147 | -2.65% | 69,570,682 | -1.86% | 88 | 0.84% | 80 | -8.05% | 39 | -17.02% |
| Jun 30, 2024 | 150 | -2.60% | 70,892,178 | 6.49% | 106 | 1.07% | 86 | 3.61% | 47 | 20.51% |
| Mar 31, 2024 | 154 | 4.76% | 66,572,511 | 0.83% | 99 | 1.02% | 83 | -10.75% | 39 | 21.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price New Horizons | 4.67M | 6.06% | -63.09K |
| US Small-Cap Growth II Equity Comp | 4.67M | 6.06% | -64.46K |
| Vanguard Total Stock Mkt Idx Inv | 2.05M | 2.66% | 63.40K |
| Vanguard US Total Market Shares ETF | 2.02M | 2.63% | 478.00K |
| iShares Russell 2000 ETF | 1.76M | 2.29% | 864.00 |
| T. Rowe Price Health Sciences | 1.67M | 2.17% | -25.24K |
| T. Rowe Price Integrated US SmCapGrEq | 1.48M | 1.92% | -1.48M |
| T. Rowe Price Integrated US Sm Gr Eq | 1.48M | 1.92% | - |
| T. Rowe Price New Horizons Tr-Z | 1.28M | 1.66% | 1.80K |
| T. Rowe Price New Horizons Tr-A | 1.28M | 1.66% | 1.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 20, 2025 | Astley-Sparke Philip | - | Sell | $260.17K |
| May 20, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell | $64.09K |
| May 20, 2025 | Schwendenman Andrew | Chief Accounting Officer | Sell | $26.46K |
| May 20, 2025 | Patel Sushil | Chief Executive Officer | Sell | $202.35K |
| May 20, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell | $20.41K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 8 |
REPL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools